February 16, 2009
 

Drugs@FDA Downloadable Data Files (updated)


Drugs@FDA Downloadable Data Files (updated)
Drugs@FDA Downloadable Data Files (updated)
Source: www.fda.gov

Drug Shortages: Resolved Drug Shortages: Alprostadil 0.5 mg/mL injection
See Related Information section
Source: www.fda.gov

January First-Time Generic Drug Approvals
Office of Generic Drugs: January First-Time Generic Drug Approvals
Source: www.fda.gov

Guidance for Industry
Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 7: Dissolution Test General Chapter
Source: www.fda.gov

Drug Shortages: Current Drug Shortages: Oxycodone Immediate Release Tablets (5mg, 15mg and 30mg)
Mallinckrodt continues to work diligently to meet the market need during this temporary period of limited supply. Xanodyne has additional releases starting February 20th, 2009. Vintage Pharmaceuticals will be releasing additional product starting February 11th, 2009.
Source: www.fda.gov

Guidance for Industry
New Revised/Withdrawn List for 2009
Source: www.fda.gov

Adverse Event Reporting System (AERS) Statistics(updated)
Adverse Event Reporting System (AERS) Statistics (updated)
Source: www.fda.gov

Forum
Conference - Cytokine Therapies: Novel Approaches for Clinical Indications, March 26 and 27, 2009, NYAS Conference Center, New York City, NY: This event is a public, two-day forum that will focus on the clinical use of cytokines and cytokines antagonists as therapeutic agents for the treatment of human diseases, including cancer and autoimmune disorders such as rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Meeting Information.
Source: www.nyas.org

Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies
Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies Conducted under Section 505A and 505B of the FDA (the Act), as amended by the FDA Amendments Act of 2007 (FDAAA)
Source: www.fda.gov

Paragraph IV Patent Certifications
Office of Generic Drugs: Paragraph IV Patent Certifications (updated)
Source: www.fda.gov

Subscribe to Posts [Atom]